Hao Weng
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Natural product bioactivities and synthesis 4
- Cell death mechanisms and regulation 3
- Surgery 11
- Cholangiocarcinoma and Gallbladder Cancer Studies 6
- Co-authors
- Hailin Zhao (3 shared papers)Yingbin Liu (33 shared papers)Maolan Li (34 shared papers)Xiangsong Wu (28 shared papers)Runfa Bao (27 shared papers)Yijun Shu (30 shared papers)Yang Cao (19 shared papers)Daqing Ma (1 shared paper)
- Journals
- BMC Cancer (3 papers)Tumor Biology (3 papers)Molecules (2 papers)Drug Design Development and Therapy (2 papers)Cancer Biology & Therapy (2 papers)
- Partner nations
- ChinaUnited KingdomHong Kong
In The Last Decade
Hao Weng
55 papers receiving 2.1k citations
Hao Weng's Hit Papers
Peers
Comparison fields: 5 of 107
- Cancer Research 432
- Anesthesiology and Pain Medicine 107
- Developmental Neuroscience 70
- Immunology 271
- Critical Care and Intensive Care Medicine 58
Countries citing papers authored by Hao Weng
This map shows the geographic impact of Hao Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Weng more than expected).
Fields of papers citing papers by Hao Weng
This network shows the impact of papers produced by Hao Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Weng. The network helps show where Hao Weng may publish in the future.
Co-authors
The 25 scholars most cited alongside Hao Weng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 257 | |
| 2 | 2014 | 206 | |
| 3 | Efficacy and safety of ciprofol for the sedation/anesthesia in patients undergoing colonoscopy: Phase IIa and IIb multi-center clinical trials Hit paper breakdown → | 2021 | 110 |
| 4 | 2015 | 106 | |
| 5 | 2014 | 100 | |
| 6 | 2020 | 88 | |
| 7 | 2013 | 82 | |
| 8 | 2014 | 81 | |
| 9 | 2019 | 81 | |
| 10 | 2017 | 74 | |
| 11 | 2017 | 73 | |
| 12 | 2015 | 66 | |
| 13 | 2018 | 57 | |
| 14 | 2015 | 54 | |
| 15 | 2014 | 50 | |
| 16 | 2015 | 49 | |
| 17 | 2016 | 44 | |
| 18 | 2014 | 41 | |
| 19 | 2015 | 38 | |
| 20 | 2013 | 35 |
About Hao Weng
Hao Weng is a scholar working on Molecular Biology, Surgery, Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 59 papers that have together received 2.1k indexed citations. Recurring topics across this work include Gallbladder and Bile Duct Disorders (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Pancreatic and Hepatic Oncology Research (5 papers), Cancer-related molecular mechanisms research (4 papers), Anesthesia and Sedative Agents (4 papers), Natural product bioactivities and synthesis (4 papers), Intensive Care Unit Cognitive Disorders (3 papers) and Cell death mechanisms and regulation (3 papers). The work is most often cited by research in Cancer Research (432 citations), Anesthesiology and Pain Medicine (107 citations), Developmental Neuroscience (70 citations), Immunology (271 citations) and Critical Care and Intensive Care Medicine (58 citations). Hao Weng has collaborated with scholars based in China, United Kingdom and Hong Kong. Frequent co-authors include Hailin Zhao, Yingbin Liu, Maolan Li, Xiangsong Wu, Runfa Bao, Yijun Shu, Yang Cao, Daqing Ma, Qian Ding and Jiasheng Mu. Their work appears in journals such as BMC Cancer, Tumor Biology, Molecules, Drug Design Development and Therapy and Cancer Biology & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.